Artificial intelligence is evolving beyond simple pattern recognition and content generation into autonomous decision-making.

Directors at the firm explain how the drafting tool works, and why they may need to strengthen their team post-launch ...

More recent case law has reinforced this principle, holding that when therapeutic and non-therapeutic effects are inseparably ...

Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma ...

A Freedom of Information (FOI) request revealed that the number of businesses claiming Patent Box relief in the UK’s ‘Golden Triangle’ region was less than 13% of the annual total of newly granted ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

Mirabegron is still covered by patents covering crystal forms ... version of its pharmacologic stress agent Lexiscan (regadenoson injection) in the US, exposing a product with around $650 million ...

The Davenport Value & Income Fund (DVIPX) generated a -4.18% total return in the fourth quarter of 2024. Click here to read ...

Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...

Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that ...